Updated:
NuVasive
NuVasive, now part of Globus Medical, was a San Diego-based medical device pioneer in minimally invasive spine surgery, acquired in 2023 for $3.1B.
NuVasive
NuVasive was founded in 1997 by its former CEO Alexis Lukianov and others, initially focused on developing less invasive surgical approaches to spinal fusion. The company generated over $1B in annual revenue prior to its acquisition by Globus Medical, which closed in September 2023. The combined organization operates under the Globus Medical brand and maintains the West Coast Experience Center in San Diego, alongside a global network of offices across North America, Europe, Asia, and Australia. NuVasive's core business spanned minimally invasive surgical systems, implants, biologics, and intraoperative neuromonitoring services. Key products included the XLIF approach for lateral lumbar fusion, the Pulse platform integrating navigation and neuromonitoring, and the NuVasive Specialized Orthopedics (NSO) line of limb-lengthening and deformity correction devices. The firm's neuromonitoring subsidiary, NCS, serves over 100,000 cases annually. Geographically, the firm sold in more than 30 countries, with direct operations in the US, Germany, the UK, Japan, Australia, and Brazil. At the time of acquisition, NuVasive employed approximately 3,400 people. The merged entity — Globus Medical — now has over 6,000 employees and a combined product portfolio spanning spine, trauma, joint reconstruction, robotics (the Excelsius platform), and intraoperative neuromonitoring. The integration was announced in April 2024 when the company reported first-quarter results, reflecting cost synergies and expanded market access. NuVasive's structural distinctiveness lay in its founding ethos: pioneering a single approach (lateral lumbar fusion) and methodically building a full surgical ecosystem around it — implants, navigation, neuromonitoring, and surgeon education — rather than acquiring growth. This integration of enabling technologies under one roof, before the acquisition by Globus, made it a vertically integrated musculoskeletal player rare among mid-cap device companies.
General information
Firm type
Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Frequently asked questions
Who makes investment decisions at NuVasive now?
NuVasive is no longer an independent public company. As of the September 2023 acquisition, all strategic and capital-allocation decisions are made by Globus Medical's management team, led by President and CEO Daniel Scavilla. No separate family office structure has been publicly identified for NuVasive or its former principals.
How was NuVasive's acquisition by Globus Medical financed?
The acquisition was an all-stock transaction. Globus Medical issued approximately 113 million shares of common stock to acquire NuVasive (per Globus Medical, September 2023). The deal valued NuVasive at $3.1B, including the assumption of debt.
What investment stages did NuVasive focus on?
NuVasive was an operating company, not an investment firm. It researched, developed, manufactured, and marketed medical devices — primarily spine surgery systems. Its capital was deployed internally into R&D, clinical trials, manufacturing, and global sales expansion.
Which sectors does NuVasive (now Globus Medical) target?
The combined entity focuses on musculoskeletal health — spine surgery, orthopedic trauma, joint reconstruction, regenerative biologics, and surgical robotics/navigation. NuVasive's core was minimally invasive spine; its acquisition merged that with Globus's broader portfolio across trauma, joint replacement, and robotics.
Where does the underlying wealth for NuVasive come from?
NuVasive was founded by orthopedic surgeons and entrepreneurs, notably Alexis Lukianov, and went public in 2004. Wealth was generated through equity value appreciation, executive compensation, and stock sales over the company's 26-year history as a publicly traded firm. No single family office or specific principal wealth vehicle has been disclosed.
Does NuVasive maintain philanthropic structures?
NuVasive had a corporate charitable giving program, including sponsorships like Team Cheetah's participation in Padres Pedal the Cause, but no independent philanthropic foundation was publicly disclosed. The company's charitable activities now fall under Globus Medical's corporate social responsibility program.
How does Globus Medical source its deal flow for acquisitions or partnerships?
Globus Medical's business development team evaluates potential acquisitions and partnerships in the musculoskeletal space primarily through direct industry relationships, surgeon advisory boards, and academic research collaborations. The company does not rely on external venture funds or a formal family-office network for sourcing.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: